Paratek Investor Day Summary and Slides
Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, hosted an Investor Day on Tuesday, October 17, 2017, from 12:00 p.m. to 3:00 p.m. ET at the Lotte Palace Hotel in New York City.
During the Investor Day, Paratek’s management team and experts in the field of antibiotics development and infectious disease will discuss progress of the clinical development program and pre-commercialization activities for omadacycline.
The meeting featured presentations by key opinion leaders including:
- George Zhanel, Ph.D., University of Manitoba
- George Sakoulas, M.D., University of California San Diego
- Fredrick M. Abrahamian, DO, FACEP, FIDSA, David Geffen School of Medicine at UCLA
10/19/2017 12:00:00 AM